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Abstract
Background: Influenza is one of the most common vaccine-preventable diseases in travellers. By performing two cross-
sectional questionnaire surveys during winter 2009 and winter 2010 among European travellers to resource-limited 
destinations, we aimed to investigate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination.
Methods: Questionnaires were distributed in the waiting room to the visitors of the University of Zurich Centre for 
Travel' Health (CTH) in January and February 2009 and January 2010 prior to travel health counselling (CTH09 and 
CTH10). Questions included demographic data, travel-related characteristics and KAP regarding influenza vaccination. 
Data were analysed by using SPSS® version 14.0 for Windows. Differences in proportions were compared using the Chi-
square test and the significance level was set at p ≤ 0.05. Predictors for seasonal and pandemic influenza vaccination 
were determined by multiple logistic regression analyses.
Results: With a response rate of 96.6%, 906 individuals were enrolled and 868 (92.5%) provided complete data. 
Seasonal influenza vaccination coverage was 13.7% (n = 119). Only 43 (14.2%) participants were vaccinated against 
pandemic influenza A/H1N1, mostly having received both vaccines simultaneously, the seasonal and pandemic one. 
Job-related purposes (44, 37%), age > 64 yrs (25, 21%) and recommendations of the family physician (27, 22.7%) were 
the most often reported reasons for being vaccinated. In the multiple logistic regression analyses of the pooled data 
increasing age (OR = 1.03, 95% CI 1.01 - 1.04), a business trip (OR = 0.39, 95% CI 0.17 - 0.92) and seasonal influenza 
vaccination in the previous winter seasons (OR = 12.91, 95% CI 8.09 - 20.58) were independent predictors for seasonal 
influenza vaccination in 2009 or 2010.
Influenza vaccination recommended by the family doctor (327, 37.7%), travel to regions with known high risk of 
influenza (305, 35.1%), and influenza vaccination required for job purposes (233, 26.8%) were most frequently 
mentioned to consider influenza vaccination.
Conclusions: Risk perception and vaccination coverage concerning seasonal and pandemic influenza was very poor 
among travellers to resource-limited destinations when compared to traditional at-risk groups. Previous access to 
influenza vaccination substantially facilitated vaccinations in the subsequent year. Information strategies about 
influenza should be intensified and include health professionals, e.g. family physicians, travel medicine practitioners 
and business enterprises.
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Background
Pandemic and seasonal influenza are still a challenging
field of the public health system. Influenza - a mild to
severe respiratory infection caused by RNA viruses of the
family Orthomyxoviridae - is one of the most common
vaccine-preventable disease in travellers. Worldwide,
between 250'000 and 500'000 deaths are estimated to be
due to seasonal influenza infection each year [1]. Influ-
enza is also responsible for tremendous economic costs
both from admissions to hospital and loss of productivity
[2]. Influenza affects all age groups and is usually self-lim-
ited. Common symptoms include acute fever, muscles
pain, headache, cough and chills [3]. Special risk groups,
such as very young children, the elderly and those suffer-
ing from chronic lung or heart diseases are at risk for seri-
ous influenza complications, e.g. bacterial pneumonia
[4,5]. Influenza reaches peak prevalence in winter in the
Northern hemisphere (Nov-Apr) - as well as in the
Southern hemisphere (Apr-Oct) and circulates year-
round in the tropics [6,7]. Seasonal influenza vaccination
is an effective prevention strategy and is therefore rou-
tinely recommended for special risk groups [8,9]. Of note,
the seasonal influenza vaccine recommendations of the
U.S. Centres for Disease Control were recently expanded
and include now about 80% of the population [10].
Influenza is known to be a quite frequent infection
among travellers to tropical and subtropical destinations
compared to other infections, e.g. vector-borne ones.
About one of hundred travellers abroad gets infected [7].
The risk of infection depends on the travel destination
and the season. Travellers crossing hemispheres may be
confronted with different antigenic variants of the influ-
enza virus. By returning home, the new variant may be
transmitted to contact persons [11]. The first pandemic
of the 21st century has highlighted the need for interna-
tional influenza prevention strategies [12].
The objective of this study was to investigate the vacci-
nation coverage as well as knowledge, attitudes and prac-
tices (KAP) regarding influenza vaccination among
travellers to resource-limited countries to improve or
adapt current preventive strategies.
Methods
Two cross-sectional surveys were conducted at the Uni-
versity of Zurich Centre for Travel' Health during January
and February 2009 and January 2010, respectively. Self-
administered, anonymous questionnaires including 16
items were distributed to travellers waiting for pre-travel
health advice. Participation was voluntary. Individuals
above 17 years, understanding German or English, resid-
ing in Switzerland and planning to travel to a resource-
limited destination were included. Questions included
demographic data (gender, age, nationality, education,
profession), travel-related characteristics (destination
country, duration of stay, influenza risk perception, previ-
ous travel health advice, travel purpose, travel costs) and
general attitudes and practices towards influenza vacci-
nation (vaccination coverage, reasons to be vaccinated,
reasons to refuse vaccination, motivations to consider
vaccination with options for multiple answers except for
the vaccination coverage). In 2010, an additional question
targeting the pandemic influenza A/H1N1 vaccination
coverage was included. The questionnaires were checked
for completeness. A written letter of exempt was received
by the Ethical Commission of the Canton of Zurich.
Statistical analyses were conducted by using SPSS® ver-
sion 14.0 for Windows. Differences in proportions of
demographics, travel-related data and attitudes and prac-
tices were compared using the Chi-square test. The sig-
nificance level was set at p ≤ 0.05. For the multiple logistic
regression analysis the surveys were analysed as well as
pooled dataset and each survey, CTH-2009 and CTH-
2010, separately. The seasonal influenza vaccination was
used as outcome and all demographic, travel-related and
attitude- and practices-related factors were evaluated as
independent predictors. Odds Ratios (OR) were deter-
mined by stepwise backward elimination of variables with
p > 0.150. For sensitivity analyses, each dataset of the
CTH studies, 2009 and 2010, was analysed separately and
additionally, predictors for pandemic influenza vaccina-
tion were determined by multiple logistic regression anal-
yses.
Results
Study population
From a total of 938 eligible individuals, 868 (92.5%) were
included in the analysis (Figure 1). Overall, 479 (55.2%)
were females and 389 (44.8%) males. The great majority
of participants (503, 57.9%) were between 18 and 35 years
old with a median age of 32 years (range 18 - 84 yrs). Only
46 (5.3%) responders were above 64 years of age. In gen-
eral, participants were highly educated with 480 (55.3%)
being university graduates. Overall, the characteristics of
participants planning to travel to resource-limited desti-
nations are presented in Table 1.
Figure 1 Flow diagram of participants.
Recruitment 2009 
n=624 (100%) 
Recruitment 2010 
n=314 (100%) 
 
Exclusion: 
no travel health advice: 2 (0.6%) 
refused participation: 6 (1.9%) 
Exclusion: 
no travel health advice: 13 (2.1%) 
refused participation: 11 (1.8%) 
Response rate: 
n=600 (96.1%) 
Response rate: 
n=306 (97.5%) 
incomplete data: 4 (1.3%)  incomplete data: 34 (5.4%) 
analysed: 566 (90.7%)  analysed: 302 (96.2%) Pfeil et al. BMC Public Health 2010, 10:402
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Table 1: Characteristics of participants planning to travel to resource-limited destinations
Characteristics All (n = 868) CTH 2009 (n = 566) CTH 2010 (n = 302) p-value
Gender: female 479 (55.2%) 313 (55.3%) 166 (55%) p = 0.925
male 389 (44.8%) 253 (44.7%) 136 (45%)
Age (yrs): mean 37 37 37 p = 1.000
median (range) 32 (18-84) 32 (18-81) 32 (18-84)
Age-groups: 18 - 35 yrs 503 (57.9%) 324 (57.2%) 179 (59.3%) p = 0.564
36 - 50 yrs 204 (23.5%) 142 (25.1%) 62 (20.5%) p = 0.131
51 - 64 yrs 115 (13.2%) 74 (13.1%) 41 (13.6%) p = 0.835
> 64 yrs 46 (5.3%) 26 (4.6%) 20 (6.6%) p = 0.204
Educational level: prim./sec. school 20 (2.3%) 13 (2.3%) 7 (2.3%)
traineeship/A-level 368 (42.4%) 241 (42.6%) 127 (42.1%)
university 480 (55.3%) 312 (55.1%) 168 (55.6%) p = 0.989
Travel continent: Africa 243 (28%) 151 (26.7%) 92 (30.5%) p = 0.237
Latin America 273 (31.5%) 198 (35%) 75 (24.8%) p = 0.002
Asia 331 (38.1%) 208 (36.7%) 123 (40.7%) p = 0.250
SE Europe 6 (0.7%) 2 (0.4%) 4 (1.3%) p = 0.744
Oceania 15 (1.7%) 7 (1.2%) 8 (2.6%) p = 0.128
Duration of stay (days): 1 - 7 days 29 (3.3%) 18 (3.2%) 11 (3.6%)
8 - 14 days 183 (21.1%) 112 (19.8%) 71 (23.5%)
15 - 28 days 342 (39.4%) 233 (41.2%) 109 (36.1%) p = 0.432
> 28 days 314 (36.2%) 203 (35.9%) 111 (36.8%)
Perceived risk of influenza 
at destination:
high 72 (8.3%) 42 (7.4%) 30 (9.9%)
low 515 (59.3%) 338 (59.7%) 177 (58.6%) p = 0.436
no idea 281 (32.4%) 186 (32.9%) 95 (31.5%)
Source of travel health 
information*:
internet 340 (39.2%) 211 (37.3%) 129 (42.7%) p = 0.118
family doctor 111 (12.8%) 74 (13.1%) 37 (12.3%) p = 0.730
family/friends 75 (8.6%) 50 (8.8%) 25 (8.3%) p = 0.781
Purpose of the journey: holidays 695 (80.1%) 448 (79.2%) 247 (81.8%) p = 0.354
VFR** 107 (12.3%) 73 (12.9%) 34 (11.3%) p = 0.484
business 92 (10.6%) 61 (10.8%) 31 (10.3%) p = 0.815
Travel expenses (CHF): 0 - 4999 564 (65%) 378 (66.8%) 186 (61.6%)
5000 - 9999 197 (22.7%) 122 (21.6%) 75 (24.8%)
10000-15000 49 (5.6%) 35 (6.2%) 14 (4.6%) p = 0.091
> 15000 31 (3.6%) 15 (2.7%) 16 (5.3%)Pfeil et al. BMC Public Health 2010, 10:402
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Travel characteristics
The majority reported travel to South America (188,
21.7%), followed by South-east Asia (170, 19.6%) and
South-central Asia (135, 15.6%). Most frequently coun-
tries planned to visit included India (125, 14.4%) and
Thailand (87, 10%). Most travellers stayed at their desti-
nation between 15 days to four weeks (342, 39.4%). Only
72 (8.3%) travellers estimated their destination as at high
risk for influenza infection, of these 17 (23.6%) were vac-
cinated against seasonal influenza. Only 111 (12.8%)
responders were informed by their family physicians in
advance, web-based information was consulted by 340
travellers (39.2%). The great majority, 695 (80.1%),
included holiday travellers, 107 (12.3%) were visiting
friends or relatives (VFR) and every tenth (92, 10.6%) was
a business traveller.
Vaccination coverage
A total of 119 (13.7%) participants were vaccinated
against seasonal influenza, 43 (14.2%) against pandemic
influenza in 2010 and 25 (8.3%) have received both influ-
enza vaccinations. The great majority (630, 72.6%) has
never received an influenza vaccination in their life. In
the multiple logistic regression analysis, increasing age
(OR = 1.03, 95% CI 1.01 - 1.04) and seasonal influenza
vaccination in the previous winter seasons (OR = 12.91,
95% CI 8.09 - 20.58) were significant predictors for being
vaccinated against seasonal influenza (Table 2). Business
travellers (OR = 0.39, 95% CI 0.17 - 0.92) were signifi-
cantly less often vaccinated than other traveller groups.
The same independent factors were determined when
analysing each survey, CTH-2009 and CTH-2010, sepa-
rately. Having received the pandemic influenza vaccina-
tion was significantly associated with having received the
seasonal influenza vaccination in winter 2009/2010 (OR
= 10.86, 95% CI 5.11 - 23.09).
KAP on seasonal influenza vaccination
Of all vaccinated participants, 44 (37%) declared to be
vaccinated for business reasons and 25 (21%) due to age
(Table 3). Only 10 (8.4%) responders reported to be vacci-
nated for their journey. Travellers remained mostly
unvaccinated (326, 43.5%) because they felt not at risk,
144 (19.2%) have missed any recommendation by their
family physician and a substantial proportion (172, 23%)
did not see any relevance for being vaccinated. Often
mentioned as "other reasons" for being unvaccinated
(108, 14.3%) included items like: rare/never affected by
influenza (43, 5.7%), vaccine is not effective enough (34,
4.5%) and bad experiences with vaccine/side-effects of
vaccine (31, 4.1%). Most travellers would consider vacci-
nation if they would feel in bad general health (408, 47%),
followed by a recommendation of the family physician
(327, 37.7%) and travel to regions with known high risk of
influenza (305, 35.1%). Of note, 65 (7.5%) intended to
refuse influenza vaccination at any time.
Discussion
Travel as risk factor for an influenza infection is poorly
established among international travellers when regard-
ing the low vaccination coverage as well as the low self-
perceived travel-associated risk estimates. Of note, previ-
ous influenza vaccinations facilitated receiving an influ-
enza vaccination in the following year by about 13 times.
Therefore, easy access to the influenza vaccine is impor-
tant. High media coverage was not considered sufficient
to increase the vaccination rate substantially as is indi-
cated by the low increase of the vaccination coverage
between the two surveys in 2009 and 2010 and also by the
low pandemic influenza vaccination coverage of only
14.2%. Therefore, multiple efforts need to complement
one another including information strategies provided by
family physicians and travel medicine practitioners, but
also job- and age-related activities need to be considered.
Our sample of travellers is comparable to other studies
performed at our Centre for Travel' Health [7] with
respect to the age distribution, educational level and
travel duration. Inherent limitations include a selection
bias: Frequently visited destinations such as the Middle
East, North Africa and the Caribbean are underrepre-
sented as travellers to those destinations generally do not
consider a pre-travel health consultation as indicated [11]
but destinations with higher risk for faecal-orally trans-
mitted infectious diseases, such as TD or bacterial men-
ingitis, are well represented, such as e.g. India and Sub-
Saharan countries. Therefore, our sample may represent
a best practice sample. The fact, that the high proportion
of university graduates indicates a health literate popula-
tion may result in an even overestimated risk perception
as well as influenza vaccination coverage. All data collec-
tions relied on self-reported information. Hence, the
results of the studies might be limited by a potential bias
Seasonal vaccination coverage 119 (13.7%) 65 (11.5%) 54 (17.9%) p = 0.009
Pandemic vaccination coverage 43 (14.2%) na 43 (14.2%) na
*prior to receiving travel health advice at the CTH (Centre for Travel Health)
VFR: people visiting friends or relatives, na: not available
p was determined with Chi-square test, statistical significance was set at p ≤ 0.05.
Table 1: Characteristics of participants planning to travel to resource-limited destinations (Continued)Pfeil et al. BMC Public Health 2010, 10:402
http://www.biomedcentral.com/1471-2458/10/402
Page 5 of 7
such as disclosure bias, although self-report of influenza
vaccination status has been found to be reliable when
checked against medical record documentation [13].
Most seasonal influenza activity occurs during Novem-
ber to April on the Northern hemisphere and vaccination
is usually administered between October and November.
Therefore, travellers visiting the opposite hemisphere
have to be counselled accordingly and the seasonal influ-
enza vaccine also for the Southern hemisphere has to be
available as there is year-round influenza activity in tropi-
cal and subtropical areas.
Conclusions
Risk perception and vaccination coverage regarding sea-
sonal and pandemic influenza was very poor among
European travellers to resource-limited destinations
Table 2: Predictors of seasonal influenza vaccination among travellers to resource-limited destinations determined by 
multiple logistic regression analysis
Variable Univariate OR
(95% CI) N = 868
Multivariate OR
(95% CI) N = 868
Final Model OR
(95% CI) N = 868
Gender 1.05 (0.71 - 1.56) 1.10 (0.69 - 1.76) 1.11 (0.70 - 1.75)
Age (yrs) 1.05 (1.03 - 1.06) 1.03 (1.01 - 1.04) 1.03 (1.01 - 1.04)
Nationality 0.98 (0.92 - 1.04)
Educational level 0.97 (0.68 - 1.38)
Travel continent 0.95 (0.76 - 1.20)
Destination by N vs. S hemisphere 1.49 (1.01 - 2.19) 1.47 (0.93 - 2.35)
Duration of stay (d) 0.74 (0.59 - 0.93) 0.74 (0.56 - 0.99) 0.78 (0.59 - 1.03)
Perceived risk of influenza at destination 0.74 (0.54 - 1.03) 0.85 (0.52 - 1.26)
Travel health advice by:
family doctor 2.05 (1.25 - 3.36) 1.50 (0.78 - 2.89)
travel clinic 1.25 (0.84 - 1.86)
internet 0.73 (0.48 - 1.09) 0.79 (0.46 - 1.34)
travel agency 0.57 (0.24 - 1.34)
family or friends 0.85 (0.41 - 1.75)
No advice 0.67 (0.41 - 1.09) 0.78 (0.42 - 1.46)
Travel purpose:
holidays 1.27 (0.76 - 2.12)
business 0.57 (0.27 - 1.21) 0.40 (0.17 - 0.97) 0.39 (0.17 - 0.92)
VFR* 1.12 (0.64 - 1.99)
education 0.58 (0.23 - 1.47)
others 0.42 (0.10 - 1.80)
Travel expenses 1.35 (1.08 - 1.69) 1.14 (0.84 - 1.56)
Previous seasonal influenza vaccination 14.39 (9.18 - 22.58) 12.42 (7.71 - 20.01) 12.91 (8.09 - 20.58)
*people visiting friends or relativesPfeil et al. BMC Public Health 2010, 10:402
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when compared to traditional at-risk groups. Age and
previous influenza vaccination were the best predictors
for considering seasonal influenza vaccination in our
population. Communication strategies about influenza
should be intensified and should include all health profes-
sionals, e.g. family physicians and travel medicine practi-
tioners, but also business enterprises.
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